Ricardo Ferreira presented our most recent results in an oral communication entitled "Wild-type p53 modification by a tryptophanol-derived oxazoloisoindolinone". The congress took place from 22 to 24 January 2024 in Faro, Portugal.
Our latest results presented at 15ENQO-8ENQT
